Sovereignty and Survival: Understanding Lung Cancer Outcomes for Aboriginal and Torres Strait Islander People in Australia, a Case–Control Study
Medical Journal of Australia · 2026
DOI: 10.5694/mja2.70278 ↗Kurz gefasst
Fachartikel in der Zeitschrift Medical Journal of Australia, 2026. Verfasst von Alice R T Bergin und 12 weiteren Autor:innen. Beteiligte Einrichtung: Peter MacCallum Cancer Centre, Melbourne, Victoria, Australia. Hauptthemen laut MEDLINE: Lung Neoplasms. Die Arbeit nennt 52 Literaturangaben. Gefördert von: Breast Cancer Research Foundation, National Health and Medical Research Council, Targeted Approaches To Improve Cancer Services for Aboriginal and Torres Strait Islander Australians Centre of Research Excellence.
Abstract (Originalsprache)
Objective
To identify factors contributing to the known increased age‐standardised incidence and mortality rates for lung cancer for Aboriginal and Torres Strait Islander people in Victoria, Australia. Study Type Retrospective, population‐based, case–control study using Victorian Cancer Registry (VCR) data and linked health administrative datasets. Setting and Participants Self‐identified Aboriginal and Torres Strait Islander people (respectfully referred to hereon as Aboriginal) and non‐Aboriginal people (aged > 18 years) diagnosed with lung cancer from 1 January 2008 to 31 December 2022. Main Outcome Measures Clinical, pathological, demographic, socio‐economic factors and biomarkers (programmed cell death‐ligand 1 [PD‐L1], anaplastic lymphoma kinase [ ALK ] and c‐ros oncogene [ ROS1 ]) were assessed. Endpoints were all‐cause and lung cancer‐specific mortality. Survival analyses were conducted using Cox regression.
Results
Aboriginal people ( N = 512) were younger ( p < 0.001), more likely to live outside a major city ( p < 0.001) and in areas of greatest disadvantage ( p < 0.001) than non‐Aboriginal people ( N = 43,468). More Aboriginal females had small cell lung cancer compared with non‐Aboriginal females (17% vs. 10%), more Aboriginal males had adenocarcinomas (41% vs. 36%) and squamous cell carcinomas (26% vs. 20%), compared with non‐Aboriginal males. There were no differences in the proportions of PD‐L1‐positive disease nor ALK or ROS1 gene rearrangements. A higher risk of all‐cause mortality (hazard ratio, 1.12; 95% CI, 1.01–1.24; p = 0.03) for Aboriginal people after stratification for age, sex and lung cancer subtype was identified.
Conclusion
This study identified that Aboriginal people were younger, more likely to be living outside of major cities and in areas of greatest inequity than non‐Aboriginal people, which is an ongoing manifestation of colonisation. Aboriginal people diagnosed with lung cancer had an increased all‐cause mortality compared with non‐Aboriginal people.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Peter MacCallum Cancer Centre, Melbourne, Victoria, Australia.
- Sir Peter MacCallum Department of Oncology, University of Melbourne, Melbourne, Victoria, Australia.
- Victorian Cancer Registry, Cancer Council Victoria, Melbourne, Victoria, Australia.
- Cancer Epidemiology Division, Cancer Council Victoria, Melbourne, Victoria, Australia.
- Centre for Epidemiology and Biostatistics, Melbourne School of Population and Global Health, University of Melbourne, Melbourne, Victoria, Australia.
- Precision Medicine, School of Clinical Sciences at Monash Health, Monash University, Melbourne, Victoria, Australia.
ORCID-Profile: Alice R T Bergin, Luc Te Marvelde, Roger L Milne, Sue M Evans
Förderung
- Breast Cancer Research Foundation
- National Health and Medical Research Council
- Targeted Approaches To Improve Cancer Services for Aboriginal and Torres Strait Islander Australians Centre of Research Excellence
- National Breast Cancer Foundation
- Victorian Comprehensive Cancer Centre Alliance Health Equity Research
- Avant Foundation
- Peter MacCallum Foundation
Zitieren
APA
Bergin, A. R. T., Te Marvelde, L., Milne, R. L., Solomon, B. J., Ivanova, K., Savas, P., Luen, S. J., Hamann, J., Casey, A., Watt, N., Evans, S. M., Garvey, G., & Loi, S. (2026). Sovereignty and Survival: Understanding Lung Cancer Outcomes for Aboriginal and Torres Strait Islander People in Australia, a Case–Control Study. Medical Journal of Australia. https://doi.org/10.5694/mja2.70278
Vancouver
Bergin ART, Te Marvelde L, Milne RL, Solomon BJ, Ivanova K, Savas P, et al. Sovereignty and Survival: Understanding Lung Cancer Outcomes for Aboriginal and Torres Strait Islander People in Australia, a Case–Control Study. Medical Journal of Australia. 2026. doi:10.5694/mja2.70278
BibTeX
@article{Bergin2026,
author = {Bergin, Alice R T and Te Marvelde, Luc and Milne, Roger L and Solomon, Benjamin J and Ivanova, Kris and Savas, Peter and Luen, Stephen J and Hamann, Jay and Casey, Andrea and Watt, Nicole and Evans, Sue M and Garvey, Gail and Loi, Sherene},
title = {Sovereignty and Survival: Understanding Lung Cancer Outcomes for Aboriginal and Torres Strait Islander People in Australia, a Case–Control Study},
journal = {Medical Journal of Australia},
year = {2026},
doi = {10.5694/mja2.70278}
}
EUVIMED